Protein decoy hinders progress of lung cancer growth in mice
Researchers have slowed the spread of a type of non-small cell lung cancer in mice by neutralising a protein that would otherwise cause tumour growth.
List view / Grid view
Researchers have slowed the spread of a type of non-small cell lung cancer in mice by neutralising a protein that would otherwise cause tumour growth.
A study on tuberous sclerosis complex has expanded the knowledge of the formation of this disease and how it can be targeted at the molecular level.
New cell experiments show more effective genetic 'cuts' that could one day become the foundation of more effective gene therapies.
Researchers have revealed that stem cells transplanted into embryonic mice can mature into fully functional lungs, a method which could be developed to grow lungs for humans.
A study has revealed the structure of an enzyme that promotes cancer growth by mutating RNA, which could be used in the development of cancer treatments.
Researchers have created a material that can manipulate the immune response and be used as a regenerative medicine therapy.
Researchers in Australia and the US have launched the first open-source database detailing genetic variants that impact human health and disease.
A recent study has revealed new findings about nerve cell development that could help to facilitate future treatment options for spinal cord injuries.
It has been discovered that papillomaviruses induce immunity that protects patients, which could lead to a novel method for preventing skin cancer using a vaccine based on T cells.
Researchers have shown that histones are vital in silencing genes and that their position is inherited in new cells, providing insight into how cancer cells can become resistant to therapy.
An AAV-delivered gene therapy has demonstrated success in animal models of temporal lobe epilepsy, so could be a therapeutic option for human patients.
The involvement of clathrin in the development of liver cancer has been described for the first time, which could lead to more targeted therapy.
A new study has demonstrated for the first time that mutations that affect myosin motor activity result in slower cell movements in vivo.
A new study that examined the protein IL-36γ could aid in the development of novel therapeutics to protect against STIs.
A study has revealed that in rhesus monkeys, a genetic mutation could be the cause of Bardet-Biedl Syndrome, providing a way to study the disease and develop therapies.